Breaking News Instant updates and real-time market news.

DIS

Disney

$144.33

-0.72 (-0.50%)

06:09
07/17/19
07/17
06:09
07/17/19
06:09

Disney collects data on Disneyland guests via 'MagicBands,' Bloomberg reports

Disney monitors usage of Disneyland's wearable "MagicBands" and smartphone apps to collect data on guests on not just their buying habits, but also what rides their kids like and who their favorite characters are, Bloomberg's Austin Carr reports. Disney has been able to use the information it collects on park guests to study how they operate and find logistic solutions not just in Disneyland, but Disney World as well, according to the report. Reference Link

  • 06

    Aug

DIS Disney
$144.33

-0.72 (-0.50%)

06/24/19
BOFA
06/24/19
NO CHANGE
BOFA
Disney's 'Toy Story 4' could generate $1B-$1.15B, says BofA/Merrill
BofA/Merrill analyst Jessica Reif Ehrlich maintained a Buy rating and $168 price target on Disney shares following the a "healthy" opening weekend at the box office for "Toy Story 4," which earned $118M domestically, an almost 7% increase on the opening weekend results for "Toy Story 3." The analyst believes "Toy Story 4" could generate between $1-$1.15bn in ultimate global box office for Disney, which could produce 23c in EPS for Disney over the life of the film. She added that the film could have favorable implications as a driver for the new Disney+ service.
07/03/19
LOOP
07/03/19
NO CHANGE
Target $11
LOOP
Hold
AMC Entertainment price target lowered to $11 from $15 at Loop Capital
Loop Capital analyst Alan Gould lowered his price target on AMC Entertainment (AMC) to $11 and kept his Hold rating to reflect the lower box office numbers in Q2. The analyst states that the stock was particularly hard hit by the company's higher leverage, with the adoption of new lease accounting rules suggesting that its debt levels doubled to $10B in the latest quarter. Gould also contends that the selloff may be overdone with much easier comparisons expected in Q3, though Q4 will bring added pressure from Disney's (DIS) launch of its OTT service and 2020 will be challenged by Disney's push out of Avatar sequel release.
07/09/19
NEED
07/09/19
NO CHANGE
NEED
Hold
Disney battle with Netflix in OTT to be 'expensive', says Needham
Needham analyst Laura Martin keeps her Hold rating on Disney (DIS), saying that while the valuation on the stock has gapped up based on investor expectations of it "winning" the OTT battle, she believes that it will take longer for the company to "displace" Netflix (NFLX) and beat the other competitors in the space. The analyst raises her FY20 revenue estimates to $83.4B from $76.6B to account for the contribution of the new Fox assets, but also lowers her EPS view by 15c to $6.39 to reflect the higher investments tied to Disney's OTT service, as the management will have to incur higher TV production costs due to digital platform competition coming from "Netflix, Hulu, Amazon (AMZN) Video, etc."
07/11/19
UBSW
07/11/19
NO CHANGE
Target $420
UBSW
Buy
Netflix is widening its 'competitive moat', says UBS
UBS analyst Eric Sheridan kept his Buy rating and $420 price target on Netflix (NFLX), saying he sees the company's competitive moat growing in strength. The analyst notes that while the launch of Disney+ (DIS) at the end of this year remains an unknown, the pricing power and content success of Netflix have resulted in "only modest" churn dynamics and "broad-based" add trends.

TODAY'S FREE FLY STORIES

ORTX

Orchard Therapeutics

$12.09

0.1 (0.83%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22
Hot Stocks
Orchard Therapeutics 'on track' to submit MAA for MLD in 1H20 »

Orchard remains on track…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BABA

Alibaba

$173.57

4.39 (2.59%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22
Recommendations
Alibaba analyst commentary  »

Daiwa expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 19

    Nov

ORTX

Orchard Therapeutics

$12.09

0.1 (0.83%)

07:21
10/22/19
10/22
07:21
10/22/19
07:21
Hot Stocks
Orchard Therapeutics presents data from OTL-200 in patients with MLD »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SWI

SolarWinds

$19.05

0.22 (1.17%)

07:20
10/22/19
10/22
07:20
10/22/19
07:20
Downgrade
SolarWinds rating change  »

SolarWinds downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

CHTR

Charter

$438.01

-2.45 (-0.56%)

07:20
10/22/19
10/22
07:20
10/22/19
07:20
Recommendations
Charter analyst commentary  »

Charter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

NVCN

Neovasc

$3.72

0.17 (4.79%)

07:18
10/22/19
10/22
07:18
10/22/19
07:18
Hot Stocks
Neovasc announces multiple presentations featuring Neovasc Reducer »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$3.08

0.17 (5.84%)

07:17
10/22/19
10/22
07:17
10/22/19
07:17
Hot Stocks
Kadmon reports FDA approval of Clovique generic product »

Kadmon Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$262.05

-0.49 (-0.19%)

07:17
10/22/19
10/22
07:17
10/22/19
07:17
Downgrade
Intuit rating change  »

Intuit downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

QTRH

Quarterhill

$1.29

0.05 (4.03%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Hot Stocks
Quarterhill names David Cortens as interim CFO, succeeding Shaun McEwan »

Quarterhill announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCY

Oncolytics

$0.47

-0.0138 (-2.83%)

, PFE

Pfizer

$36.45

-0.01 (-0.03%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Hot Stocks
Oncolytics, PrECOG announce collaboration for Bracelet-1 study in metastatic BC »

Oncolytics Biotech (ONCY)…

ONCY

Oncolytics

$0.47

-0.0138 (-2.83%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

KMT

Kennametal

$29.76

-0.97 (-3.16%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Recommendations
Kennametal analyst commentary  »

Kennametal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 05

    Nov

  • 14

    Nov

ETON

Eton Pharmaceuticals

$5.66

-0.395 (-6.52%)

07:14
10/22/19
10/22
07:14
10/22/19
07:14
Hot Stocks
Eton Pharmaceuticals announces FDA approval of Biorphen injection »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

WDAY

Workday

$154.10

-0.54 (-0.35%)

07:14
10/22/19
10/22
07:14
10/22/19
07:14
Upgrade
Workday rating change  »

Workday upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$118.56

1.23 (1.05%)

07:13
10/22/19
10/22
07:13
10/22/19
07:13
Hot Stocks
UPS announces retirement of COO Jim Barber »

UPS announced COO Jim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:11
10/22/19
10/22
07:11
10/22/19
07:11
Earnings
Interpublic Group 'on track' to deliver high end of 2%-3% organic growth in 2019 »

Consensus $8.65B. CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$240.49

4.2 (1.78%)

07:11
10/22/19
10/22
07:11
10/22/19
07:11
Recommendations
Apple analyst commentary  »

KeyBanc views near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

07:10
10/22/19
10/22
07:10
10/22/19
07:10
Hot Stocks
Procter & Gamble: Q1 operating profit margin increased 280 basis points »

Operating profit margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Procter & Gamble: Q1 reported gross margin increased 180 basis points »

Q1 Reported gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VCYT

Veracyte

$26.18

1.52 (6.16%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Veracyte announces preliminary nasal swab test clinical data »

Veracyte announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Dec

PRVB

Provention Bio

$6.09

-0.48 (-7.31%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Provention Bio announces results from Phase 2a PRINCE clinical trial »

Provention Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAN

Anaplan

$44.35

0.34 (0.77%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Upgrade
Anaplan rating change  »

Anaplan upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:08
10/22/19
10/22
07:08
10/22/19
07:08
Earnings
Interpublic Group reports Q3 adjusted EPS 49c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CSIQ

Canadian Solar

$18.51

0.39 (2.15%)

07:07
10/22/19
10/22
07:07
10/22/19
07:07
Hot Stocks
Canadian Solar awarded 30 MWp project in Japan »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

BBY

Best Buy

$71.51

0.89 (1.26%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Hot Stocks
Best Buy announces free next-day shipping for holiday season »

Best Buy announced free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

SGEN

Seattle Genetics

$100.86

13.44 (15.37%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.